Nine years' review on preseptal and orbital cellulitis and emergence of community-acquired methicillin-resistant Staphylococus aureus in a tertiary hospital in India

Indian Journal of Ophthalmology
Datta G PandianRenuka Srinivasan

Abstract

Preseptal cellulitis is the commonest orbital disease which frequently needs to be differentiated from orbital cellulitis. Prompt diagnosis and treatment with appropriate antibiotics can prevent vision loss and life-threatening complications of orbital cellulitis. To describe the clinical profile of cases with preseptal and orbital cellulitis admitted to a tertiary care hospital during a period of nine years. The causative organisms and the clinical outcome were analyzed. Retrospective descriptive case study done in a tertiary care hospital in South India. The in-patient records of patients with preseptal and orbital cellulitis were reviewed from 1998 to 2006. The factors reviewed included ocular findings aiding in the distinction of the two clinical conditions, the duration of symptoms, the duration of hospital stay, microbiological culture report of pus or wound swab, blood culture, drugs used for treatment, the response to therapy and complications. Descriptive analysis. One hundred and ten cases, 77 patients with preseptal cellulitis and 33 patients with orbital cellulitis were reviewed. Five percent of children and 21% of adults presented with cutaneous anthrax contributing to preseptal cellulitis. Thirty-nine percent case...Continue Reading

References

Dec 1, 1992·The British Journal of Ophthalmology·A AmraouiK Zaghloul
Mar 1, 1989·The British Journal of Ophthalmology·E Hodges, K F Tabbara
Mar 1, 1986·The British Journal of Ophthalmology·D J Bergin, J E Wright
Jan 1, 1980·AJR. American Journal of Roentgenology·R A Zimmerman, L T Bilaniuk
Apr 4, 2001·Acta Ophthalmologica Scandinavica·H G SoysalO F Recep
Oct 21, 2006·Journal of the Chinese Medical Association : JCMA·I-Ting LiuWen-Ming Hsu
Mar 31, 2010·Emerging Infectious Diseases·Aaron M MilstoneTrish M Perl

Citations

Jul 25, 2014·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Hans-J WelkoborskyMichael L Hinni
Mar 13, 2015·International Ophthalmology·Grant GillilandConnor Gilliland
Jun 5, 2014·Ophthalmic Plastic and Reconstructive Surgery·José Contreras-RuizRubén Lopez-Oliver
Jul 2, 2019·Current Opinion in Ophthalmology·Katherine J Williams, Richard C Allen
Oct 18, 2016·Ophthalmic Plastic and Reconstructive Surgery·Anaïs L CarniciuSuzanne K Freitag
Jan 19, 2019·Journal of Clinical Medicine·Sara TorrettaLorenzo Pignataro
Sep 21, 2016·Expert Review of Anti-infective Therapy·Kyungmin Huh, Doo Ryeon Chung
Mar 10, 2017·Journal of Ophthalmic Inflammation and Infection·Ahmed Mohamed Kamal ElshafeiRaafat Mohyeldeen Abdelrahman Abdallah
Oct 31, 2018·Wiener klinische Wochenschrift·Milan IvaniševićMladen Lešin

Methods Mentioned

BETA
X-ray

Related Concepts

Anthrax Disease
Hospitalization
Staphylococcal Infections
Community-Acquired Infections
Orbital Cellulitis
Methicillin resistant Staphylococcus aureus (organism)
Antibiotics
Cellulitis
Complication
Eye

Related Feeds

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

The Pediatric Infectious Disease Journal
C R Starkey, R W Steele
Cutaneous and Ocular Toxicology
Oktay EsmerAyse Serap Karadag
© 2021 Meta ULC. All rights reserved